Deals
Labcorp agrees to buy OPKO's BioReference testing businesses and 4Kscore test for up to $872 million
The $722 million upfront payment is worth about 70% of OPKO's market value before the deal. Hitting the full $150 million earnout would take far more 4Kscore sales than the test makes today.